Cargando…
The Effect of Oral Simvastatin on the Clinical Outcome of Patients with Severe Traumatic Brain Injury: A Randomized Clinical Trial
BACKGROUND: Despite recent promising pharmacological and technological advances in neurosurgical intensive care, the overall TBI-related mortality and morbidity remain high and still pose a major clinical problem. The aim of this study was to evaluate the effect of oral simvastatin on the clinical o...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research and Publications Office of Jimma
University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512953/ https://www.ncbi.nlm.nih.gov/pubmed/34703180 http://dx.doi.org/10.4314/ejhs.v31i4.15 |
_version_ | 1784583123108888576 |
---|---|
author | Shafiee, Sajad Zali, Alireza Shafizad, Misagh Emami Zeydi, Amir Ehteshami, Saeid Rezaii, Fatemeh Tafakhori, Abbas Ertiaei, Abolhasan Darvishi-Khezri, Hadi Khademloo, Mohammad Khoshnood, Reza Jalili |
author_facet | Shafiee, Sajad Zali, Alireza Shafizad, Misagh Emami Zeydi, Amir Ehteshami, Saeid Rezaii, Fatemeh Tafakhori, Abbas Ertiaei, Abolhasan Darvishi-Khezri, Hadi Khademloo, Mohammad Khoshnood, Reza Jalili |
author_sort | Shafiee, Sajad |
collection | PubMed |
description | BACKGROUND: Despite recent promising pharmacological and technological advances in neurosurgical intensive care, the overall TBI-related mortality and morbidity remain high and still pose a major clinical problem. The aim of this study was to evaluate the effect of oral simvastatin on the clinical outcome of patients with severe TBI. METHODS: In a double-blind placebo-controlled randomized clinical trial a total of 98 patients with severe TBI in Imam Khomeini Hospital in Sari, Iran, were evaluated. Patients who meet the inclusion criteria were randomly allocated into two groups (n=49). In addition to supportive therapies, the intervention group received oral simvastatin (40 mg, daily) for 10 days, and the control group received the placebo (10 days). Patients' Glasgow coma scale (GCS) score, in hospital mortality, duration of mechanical ventilation and length of ICU and neurosurgery ward stay were evaluated during three-time intervals (T1: admission, T2: discharge and T3: one month after discharge). RESULTS: The percentage of conscious patients was 18.9% (7 cases) in the simvastatin group and 3.1% (1 case) in controls (P=0.06) at T2. One month after discharge (T3) the proportion of conscious patients significantly increased in the simvastatin group compared to control group (64.9 % versus 28.1 %; P=0.002). There was no significant difference for the mean of GCS score between the simvastatin group and control group at T1 (6.41 ± 1.30 versus 6.41 ± 1.28, respectively; P = 0.98). However, the mean score of GCS in patients who received simvastatin was significantly greater than controls at T2 and T3 (p<0.05). There was no significant differences between two group in-terms of length of mechanical ventilation, ICU and neurosurgery ward stay. CONCLUSION: According to the results of this study it seems that using simvastatin may be an effective and promising therapeutic modality for improving GCS score during TBI recovery. |
format | Online Article Text |
id | pubmed-8512953 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Research and Publications Office of Jimma
University |
record_format | MEDLINE/PubMed |
spelling | pubmed-85129532021-10-25 The Effect of Oral Simvastatin on the Clinical Outcome of Patients with Severe Traumatic Brain Injury: A Randomized Clinical Trial Shafiee, Sajad Zali, Alireza Shafizad, Misagh Emami Zeydi, Amir Ehteshami, Saeid Rezaii, Fatemeh Tafakhori, Abbas Ertiaei, Abolhasan Darvishi-Khezri, Hadi Khademloo, Mohammad Khoshnood, Reza Jalili Ethiop J Health Sci Original Article BACKGROUND: Despite recent promising pharmacological and technological advances in neurosurgical intensive care, the overall TBI-related mortality and morbidity remain high and still pose a major clinical problem. The aim of this study was to evaluate the effect of oral simvastatin on the clinical outcome of patients with severe TBI. METHODS: In a double-blind placebo-controlled randomized clinical trial a total of 98 patients with severe TBI in Imam Khomeini Hospital in Sari, Iran, were evaluated. Patients who meet the inclusion criteria were randomly allocated into two groups (n=49). In addition to supportive therapies, the intervention group received oral simvastatin (40 mg, daily) for 10 days, and the control group received the placebo (10 days). Patients' Glasgow coma scale (GCS) score, in hospital mortality, duration of mechanical ventilation and length of ICU and neurosurgery ward stay were evaluated during three-time intervals (T1: admission, T2: discharge and T3: one month after discharge). RESULTS: The percentage of conscious patients was 18.9% (7 cases) in the simvastatin group and 3.1% (1 case) in controls (P=0.06) at T2. One month after discharge (T3) the proportion of conscious patients significantly increased in the simvastatin group compared to control group (64.9 % versus 28.1 %; P=0.002). There was no significant difference for the mean of GCS score between the simvastatin group and control group at T1 (6.41 ± 1.30 versus 6.41 ± 1.28, respectively; P = 0.98). However, the mean score of GCS in patients who received simvastatin was significantly greater than controls at T2 and T3 (p<0.05). There was no significant differences between two group in-terms of length of mechanical ventilation, ICU and neurosurgery ward stay. CONCLUSION: According to the results of this study it seems that using simvastatin may be an effective and promising therapeutic modality for improving GCS score during TBI recovery. Research and Publications Office of Jimma University 2021-07 /pmc/articles/PMC8512953/ /pubmed/34703180 http://dx.doi.org/10.4314/ejhs.v31i4.15 Text en © 2021 Shafiee S., et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Original Article Shafiee, Sajad Zali, Alireza Shafizad, Misagh Emami Zeydi, Amir Ehteshami, Saeid Rezaii, Fatemeh Tafakhori, Abbas Ertiaei, Abolhasan Darvishi-Khezri, Hadi Khademloo, Mohammad Khoshnood, Reza Jalili The Effect of Oral Simvastatin on the Clinical Outcome of Patients with Severe Traumatic Brain Injury: A Randomized Clinical Trial |
title | The Effect of Oral Simvastatin on the Clinical Outcome of Patients
with Severe Traumatic Brain Injury: A Randomized Clinical Trial |
title_full | The Effect of Oral Simvastatin on the Clinical Outcome of Patients
with Severe Traumatic Brain Injury: A Randomized Clinical Trial |
title_fullStr | The Effect of Oral Simvastatin on the Clinical Outcome of Patients
with Severe Traumatic Brain Injury: A Randomized Clinical Trial |
title_full_unstemmed | The Effect of Oral Simvastatin on the Clinical Outcome of Patients
with Severe Traumatic Brain Injury: A Randomized Clinical Trial |
title_short | The Effect of Oral Simvastatin on the Clinical Outcome of Patients
with Severe Traumatic Brain Injury: A Randomized Clinical Trial |
title_sort | effect of oral simvastatin on the clinical outcome of patients
with severe traumatic brain injury: a randomized clinical trial |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512953/ https://www.ncbi.nlm.nih.gov/pubmed/34703180 http://dx.doi.org/10.4314/ejhs.v31i4.15 |
work_keys_str_mv | AT shafieesajad theeffectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT zalialireza theeffectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT shafizadmisagh theeffectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT emamizeydiamir theeffectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT ehteshamisaeid theeffectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT rezaiifatemeh theeffectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT tafakhoriabbas theeffectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT ertiaeiabolhasan theeffectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT darvishikhezrihadi theeffectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT khademloomohammad theeffectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT khoshnoodrezajalili theeffectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT shafieesajad effectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT zalialireza effectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT shafizadmisagh effectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT emamizeydiamir effectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT ehteshamisaeid effectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT rezaiifatemeh effectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT tafakhoriabbas effectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT ertiaeiabolhasan effectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT darvishikhezrihadi effectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT khademloomohammad effectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial AT khoshnoodrezajalili effectoforalsimvastatinontheclinicaloutcomeofpatientswithseveretraumaticbraininjuryarandomizedclinicaltrial |